# Health-related quality of life in patients receiving medicinal cannabis: systematic review and meta-analysis of primary research findings 2015-2025. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/health-related-quality-of-life-medicinal-cannabis/ > **Published:** 2026-03-24T16:38:16-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:57:44-04:00 > **Clinical Summary:** Explore health-related quality of life medicinal cannabis outcomes in chronic conditions through a systematic review and meta-analysis from 2015-2025. --- CED Clinical Relevance  #100High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. 🔬 Evidence Watch  |  CED Clinic Quality Of Life[Chronic Pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/)Meta-AnalysisPatient-Reported Outcomes[Evidence-Based Medicine](https://cedclinic.com/digital-health-expertise-modern-challenge/) Journal Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation Study Type Randomized Trial Population Human participants Why This Matters This is the first comprehensive meta-analysis examining health-related quality of life outcomes across all chronic conditions treated with medicinal cannabis, providing much-needed standardization of outcome measurement. Quality of life represents a primary treatment goal for most patients seeking [cannabis therapy](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/), yet has been inconsistently measured and reported in [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/). Clinical Summary This systematic review and meta-analysis examined validated HRQL measures in medicinal cannabis studies from 2015-2025 across multiple databases. The authors evaluated how studies justified, measured, and reported quality of life outcomes, conducting separate meta-analyses for short-term (2 weeks-3 months), medium-term (3-12 months), and long-term (≥12 months) follow-up periods. Risk of bias assessment was performed for randomized controlled trials. The study addresses a critical gap in [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) by standardizing quality of life outcome measurement across diverse chronic health conditions. Dr. Caplan’s Take “I’ve long observed that patients consistently report improved quality of life with [cannabis therapy](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/), but we’ve lacked rigorous synthesis of this evidence across conditions and timeframes. This meta-analysis provides the systematic framework clinicians need to counsel patients about realistic HRQL expectations.” Clinical Perspective 🧠 Clinicians should use this evidence to set appropriate expectations about quality of life improvements with medicinal cannabis therapy across different timeframes. The standardized approach to HRQL measurement described here should guide future [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) design and help establish more consistent outcome reporting in clinical practice. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Health-related%20quality%20of%20life%20in%20patients%20receiving%20medicinal%20cannabis%3A%20systema...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41621036/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41621036/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Health-related%20quality%20of%20life%20in%20patients%20receiving%20medicinal%20cannabis%3A%20systema...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41621036/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41621036/](https://pubmed.ncbi.nlm.nih.gov/41621036/) Table of Contents - [FAQ](#FAQ)[Does medicinal cannabis improve quality of life in patients with chronic conditions?](#Does_medicinal_cannabis_improve_quality_of_life_in_patients_with_chronic_conditions) - [How long does it take to see quality of life improvements with medicinal cannabis?](#How_long_does_it_take_to_see_quality_of_life_improvements_with_medicinal_cannabis) - [What chronic conditions were studied for quality of life outcomes with medicinal cannabis?](#What_chronic_conditions_were_studied_for_quality_of_life_outcomes_with_medicinal_cannabis) - [How reliable is the evidence for quality of life improvements with medicinal cannabis?](#How_reliable_is_the_evidence_for_quality_of_life_improvements_with_medicinal_cannabis) - [What should clinicians consider when evaluating medicinal cannabis for patient quality of life?](#What_should_clinicians_consider_when_evaluating_medicinal_cannabis_for_patient_quality_of_life) - [Related](#Related) ## FAQ #### Does medicinal cannabis improve quality of life in patients with chronic conditions? This systematic review and meta-analysis found evidence that medicinal cannabis can improve health-related quality of life (HRQL) in patients with chronic health conditions. The analysis examined both short-term (2 weeks to 3 months) and longer-term outcomes using validated HRQL measurement tools. #### How long does it take to see quality of life improvements with medicinal cannabis? The study analyzed HRQL outcomes across three time periods: short-term (2 weeks to 3 months), medium-term (3 to 12 months), and long-term (12+ months). Evidence suggests quality of life improvements can be observed within the short-term period, though the durability and magnitude of benefits may vary by time frame. #### What chronic conditions were studied for quality of life outcomes with medicinal cannabis? The systematic review included studies examining medicinal cannabis for any chronic health condition, with [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/) being specifically highlighted as a focus area. The research encompassed various chronic conditions where patients experience reduced quality of life and may benefit from medicinal cannabis therapy. #### How reliable is the evidence for quality of life improvements with medicinal cannabis? The study used validated HRQL measurement tools and assessed risk of bias in randomized controlled trials to ensure evidence quality. The systematic review methodology, including independent screening by two reviewers and meta-analysis of primary research, provides a robust evidence base for clinical decision-making. #### What should clinicians consider when evaluating medicinal cannabis for patient quality of life? Clinicians should use validated HRQL measurement tools to assess baseline quality of life and monitor treatment response over time. The evidence supports considering medicinal cannabis as a treatment option for chronic conditions where conventional therapies may be insufficient, with careful attention to patient-reported outcomes and individualized treatment approaches. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Health-related quality of life in patients receiving medicinal cannabis: systematic review and meta-analysis of primary research findings 2015-2025.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41621036/”, “about”: “quality life research international journal quality”, “isPartOf”: “Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Health-related quality of life in patients receiving medicinal cannabis: systematic review and meta-analysis of primary research findings 2015-2025.](https://cedclinic.com/medicinal-cannabis-quality-of-life-systematic-review-2025/) A detailed systematic review and meta-analysis focusing on quality of life outcomes in patients treated with medicinal cannabis. [Read the full review](https://cedclinic.com/medicinal-cannabis-quality-of-life-systematic-review-2025/) [Cannabinoids for Nerve Pain: What the Best Clinical Evidence Says About Sleep and Pain Relief](https://cedclinic.com/cannabinoid-therapy-neuropathic-pain-sleep-relief/) Explore clinical evidence on cannabinoids for neuropathic pain and their impact on sleep and pain relief. [Learn more about cannabinoids](https://cedclinic.com/cannabinoid-therapy-neuropathic-pain-sleep-relief/) [Cannabinoid Clinical Trials for Mental & Substance Disorders](https://cedclinic.com/cannabinoid-clinical-trials-mental-disorders-evidence-2/) Review current [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) investigating cannabinoids for mental health and substance use disorders. [Explore clinical trials](https://cedclinic.com/cannabinoid-clinical-trials-mental-disorders-evidence-2/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).